Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
KLOW is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu, and KPV, commonly examined in laboratory environments for their collective influence on cellular signaling pathways related to tissue response and inflammatory modulation
Recent reports from the scientific world indicate that this peptide may play a significant role in treating injuries of the musculoskeletal system
$5.00 $8.50Price range: $5.00 through $8.50 Related Products Related products Peptides MT-2 $32.00 Select options This product has multiple variants
July 23, 2026: Pharmacy Compounding Advisory Committee meeting The FDA has scheduled a Pharmacy Compounding Advisory Committee (PCAC) meeting for July 23, 2026 to evaluate BPC-157 and TB-500 (free base and acetate forms), along with KPV and MOTs-C
Instead, gently roll the vial between your palms
Quantitative analysis of collagen development as well as granulation tissue formation and angiogenesis was performed in vivo models, incisional skin wounds, coloncolon anastomoses, and synthetic sponge implants (Seiwerth et al., 1997)
00305-3/asset/e4d9e37e-b274-4b15-adaf-e8d549a8bd51/main.assets/gr2_lrg.jpg)
